Unlisted Deals:
×

Dr Fresh Assets Annual Reports, Balance Sheet and Financials

Last Traded Price 45.00 + 0.00 %

Dr Fresh Assets Limited (Dr Fresh Assets) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Dr Fresh Assets Limited

Dr. Fresh Assets Limited Consolidated Balance Sheet (Rs. in Lakhs)

Particulars

31-03-2025

31-03-2024

Non-current assets

 

 

Property, plant and equipment

1,326.87

1,318.42

Investments

1,638.96

1,750.57

Other Financial Assets

1.93

4.14

Current assets

 

 

Inventories

1,287.98

1,306.89

Investments

761.22

853.07

Loans

342.71

368.71

Trade Receivables

584.25

620.53

Cash and cash equivalents

266.43

96.00

Other Financial Assets

69.60

38.75

Income Tax Assets (Net)

80.88

88.28

Other Current assets

1,392.97

1,194.91

Total Assets

7,753.80

7,640.24

Equity

 

 

Equity Share capital

1,082.03

1,082.03

Share Application Money

-

6.09

Other Equity

3,995.28

3,908.65

Minority Interest

43.48

-

Non-Current liabilities

 

 

Borrowings

32.35

30.75

Other financial liabilities

12.70

12.30

Provisions

16.58

13.19

Deferred tax liabilities (net)

181.56

329.07

Current liabilities

 

 

Borrowings

677.00

717.00

Trade and Other Payables

2.63

1.73

Provisions

27.71

5.80

Other Current Liabilities

1,682.51

1,533.64

Total Equity and Liabilities

7,753.80

7,640.24

 Dr. Fresh Assets Limited Consolidated Profit and Loss Account (Rs. in Lakhs)

Particulars

31-03-2025

31-03-2024

Income from Operation

 

 

Net Sales/Income from Operations

648.89

476.74

Total Income from Operation

648.89

476.74

Expenses

 

 

Purchase Traded Goods

50.93

51.00

Changes in Inventory of Traded Goods

18.32

3.96

Employees Benefit Expenses

338.25

288.52

Depreciation

16.40

18.14

Other Expenses

325.67

280.21

Total Expenses

749.57

641.84

Profit/(Loss) from operations before other income,

finance costs and Exceptional items

(100.69)

(165.10)

Other Income

197.09

380.10

Profit/(Loss) from ordinary activities before

finance costs and Exceptional items

96.41

215.00

Finance Costs

6.82

10.28

Profit/(Loss) from ordinary activities after

finance costs but before Exceptional items

89.58

204.72

Profit/(Loss) from ordinary activities before tax

89.58

204.72

Current Tax

25.08

4.61

Earlier year taxes

0.03

0.62

Deferred tax (Assets)/Liabilities

(35.82)

33.58

MAT Credit Entitlement

20.00

9.46

Profit/(Loss) from ordinary activities after tax

80.29

156.45

Net Profit / (Loss) for the period

80.29

156.45

Minority Interest

(0.66)

-

Net Profit / (Loss) after taxes, minority interest

80.95

156.45

Other Comprehensive Income (Net of tax)

 

 

Items that will not be reclassified to profit or Loss

0.05

552.27

Total Comprehensive Income for the period

81.00

708.71

Paid up equity share capital (Face Value of Rs.10 per share)

1,077.91

1,077.91

Other Equity

3995.28

3908.65

Basic and Diluted EPS for the period, for the

year to date and for the previous year

0.74

1.44

Dr. Fresh Assets Limited Consolidated Cash Flow Statement (Rs. in Lakhs)

Particulars

31-03-2025

31-03-2024

Cash Flow from Operating Activities

 

 

Net Profit / (Loss) before Tax and after impairment Loss

89.58

204.72

Adjustments For:

 

 

Interest Income

(48.32)

(35.63)

Finance Income

(0.30)

(0.95)

Depreciation

16.40

18.14

Interest/ Finance Charges

6.82

10.28

Employee Benefit paid

-

(0.11)

Provision for Employee Benefits

2.59

2.06

Liability no longer required written back

(72.68)

(92.40)

Diminution in value of investment

18.90

(194.57)

Irrecoverable advances written off

2.16

0.05

Provision for expected credit loss for debtors

(0.29)

0.12

Exchange Fluctuation

(12.21)

4.49

Loss/(Profit) on sale of investments (net)

(7.40)

0.10

Loss/(Profit) on sale of fixed assets (net)

-

0.22

Operating Profit/(Loss) before Working Capital Charges

(4.75)

(83.49)

Working Capital adjustments:

 

 

Inventories

18.90

2.10

Trade and Other Receivables- Non-Current

0.21

-

Trade and Other Receivables- Current

(174.67)

(54.20)

Other Current Assets

(0.23)

(2.87)

Trade and Other Payables- Non-Current 

72.68

93.15

Trade and Other Payables- Current 

163.31

124.26

Cash generated from Operating Activities

75.46

78.96

Direct taxes paid/adjusted

(15.97)

(19.52)

Net Cash Flow (Used in)/ Generated from Operating Activates

59.49

59.44

Cash Flow from Investing Activities

 

 

Purchase of Fixed Assets

(11.61)

(17.67)

Purchase of Investments

(63.13)

(75.06)

Sale of Investments

143.36

121.37

Sale of Fixed Assets

-

0.01

Loans Recd back/(Given)

26.00

(25.31)

Interest Received

17.47

45.03

Net Cash Flow (Used in)/ Generated from Investing Activities

112.09

48.37

Cash Flow from Financing Activities

 

 

Proceeds from Share Application Money

49.00

6.09

Proceeds / (Repayment) of Short-term loans

(38.40)

(190.86)

Interest/ Finance charges paid

(11.74)

(5.18)

Net Cash Flow (Used in)/ Generated from Financing Activities

(1.14)

(189.95)

Net Changes in Cash and cash equivalents during the year 

170.44

(82.15)

Cash and cash equivalents at beginning of the year

96.00

178.14

Cash and cash equivalents at the end of the year

266.43

96.00

Here is a summary of the Cash Flow Statement for the years 2025 and 2024:

Cash Flow from Operating Activities

In the year ending 31st March 2025, the company generated a positive cash flow of ₹59.49 lakhs from its core operations, almost the same as ₹59.44 lakhs in the previous year. While the net profit before tax was ₹89.58 lakhs, this was reduced by adjustments like interest income, write-backs of liabilities, and some provisions. Positive changes in payables helped offset higher receivables, keeping the operating cash flow steady.

Cash Flow from Investing Activities

The company recorded a net inflow of ₹112.09 lakhs from investing activities in 2025, compared to ₹48.37 lakhs in 2024. This higher inflow mainly came from proceeds on sale of investments (₹143.36 lakhs) and loans received back (₹26.00 lakhs), which together outweighed purchases of new investments and fixed assets.

Cash Flow from Financing Activities

In 2025, the company had a small net outflow of ₹1.14 lakhs from financing activities, a significant improvement from the larger outflow of ₹189.95 lakhs in the previous year. This year included proceeds from share application money (₹49.00 lakhs) that partly offset repayments of short-term loans and interest paid.

Net Change in Cash and Cash Equivalents

Overall, the company’s cash position improved with a net increase of ₹170.44 lakhs during the year. The closing cash balance rose from ₹96.00 lakhs to ₹266.43 lakhs, showing stronger liquidity at year-end compared to the previous year’s decline.

Dr Fresh Assets Annual Report

Dr Fresh Assets Annual Report 24-25

Download

Dr Fresh Assets Annual Report 2023-24

Download

Dr Fresh Assets Annual Report 2022-23

Download

Dr Fresh Assets Annual Report 2021-22

Download

Audited Financial Results for Q4 and Year ended 31 March, 2025

Download
Support Puja Support Ishika Support Purvi

News Alert